Blattner

Scarabs Genomics is a biotechnology company that specializes in the development and commercialization of the Clean Genome E. coli platform. Founded by Dr. Frederick Blattner, the company utilizes a proprietary genome-reduction technology to create optimized microbial strains for the production of recombinant proteins, DNA vaccines, and other biologics. By removing non-essential genes, mobile elements, and cryptic prophages, Scarabs provides a more stable and efficient expression system that reduces metabolic burden and improves product purity. The company offers its specialized strains and contract manufacturing services to pharmaceutical and biotechnology partners seeking to enhance their bioproduction capabilities.